Xbrane Drops Keytruda Rival As It Pares Down Pipeline And Personnel

Swedish Biosimilars Developer Discloses ‘Unfortunately Necessary Measures’ To Cut Costs

Coin Stacks, Wooden Blocks, 2025 target
Xbrane is aiming to achieve positive cash flow by Q1 2025 • Source: Shutterstock

More from Strategy

More from Business